Rallybio Corp. (RLYB)
16.84
+0.05
(+0.30%)
USD |
NASDAQ |
Sep 01, 16:00
16.84
0.00 (0.00%)
After-Hours: 19:49
Rallybio Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.055M |
| December 31, 2025 | 0.082M |
| September 30, 2025 | 0.108M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.058M |
| March 31, 2024 | 0.116M |
| December 31, 2023 | 0.173M |
| September 30, 2023 | 0.211M |
| June 30, 2023 | 0.266M |
| Date | Value |
|---|---|
| March 31, 2023 | 0.321M |
| December 31, 2022 | 0.374M |
| September 30, 2022 | 0.428M |
| June 30, 2022 | 0.478M |
| March 31, 2022 | 0.517M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Q32 Bio, Inc. | 4.561M |
| Beam Therapeutics, Inc. | 232.15M |
| C4 Therapeutics, Inc. | 50.18M |
| Cullinan Therapeutics, Inc. | 1.405M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |